Literature DB >> 33576951

Psychopathology and Quality of Life in Children with Epilepsy: A Cross-Sectional Study.

Prahbhjot Malhi1, Annapoorni Annam2, Pratibha Singhi2.   

Abstract

The study examined the relationship between psychopathology, seizure-related variables, and quality of life in children with epilepsy. Seventy-nine children with active epilepsy (Mean = 10.1 y, SD = 2.68) were consecutively recruited from the outpatient services of an advanced pediatric hospital. The Quality-of-Life in Childhood Epilepsy questionnaire and the Childhood Psychopathology Measurement Schedule (CPMS) were administered to the parents. The most compromised health-related quality of life (HRQOL) domain was the general health domain (Mean = 61.70, SD = 26.81). The mean intelligence quotient (IQ) score was 81.59 (SD = 12.34) and only 20% had IQs in the normal average range. The mean CPMS score was 7.41 (SD = 5.41). The psychopathology score and the IQ explained 43% of the variance in the total HRQOL score (F = 28.67, P = 0.0001) in the regression analysis. Childhood epilepsy is a significant public health concern and a multidisciplinary approach to management would help in addressing the multiple needs of the children with epilepsy and their families.

Entities:  

Keywords:  Childhood epilepsy; Health-related quality of life; Psychopathology; Seizure severity

Year:  2021        PMID: 33576951     DOI: 10.1007/s12098-021-03685-w

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  1 in total

1.  Childhood psychopathology meausrement schedule: development and standardization.

Authors:  S Malhotra; V K Varma; S K Verma; A Malhotra
Journal:  Indian J Psychiatry       Date:  1988-10       Impact factor: 1.759

  1 in total
  1 in total

1.  Screening Children with Epilepsy for Behavioral Problems: Utility of the Strength and the Difficulties Questionnaire.

Authors:  Prahbhjot Malhi; Annapoorni Annam; Pratibha Singhi
Journal:  Ann Indian Acad Neurol       Date:  2021-12-14       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.